Cargando…

A clinical grade cell-based artificial APT, aAPC/mOKT3, for unbiased expansion of CD3+ T lymphocytes

Detalles Bibliográficos
Autores principales:	Sotov, Valentin, Ochi, Toshiki, Gray, Diana, Boguslavsky, Shlomit, Motta, Vinicius, Hirano, Naoto, Butler, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288658/ http://dx.doi.org/10.1186/2051-1426-2-S3-P5

Ejemplares similares

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
por: East, James E., et al.
Publicado: (2012)

Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads
por: Yang, Li‐Rong, et al.
Publicado: (2020)

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy
por: Forget, Marie-Andrée, et al.
Publicado: (2013)

Nanovesicles released by OKT3 hybridoma express fully active antibodies
por: Logozzi, Mariantonia, et al.
Publicado: (2021)

Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.
por: Roayaie, S, et al.
Publicado: (2000)

Csak okt berben indul újra az LHC
Publicado: (2009)

T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4
Publicado: (1984)

Spustenie najv šieho urýchľova a astíc odložili na okt ber
Publicado: (2009)

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis
por: Boden, Elisa K, et al.
Publicado: (2019)

Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies
Publicado: (1982)

APT Accelerator Technology
por: Schneider, J D
Publicado: (1996)

LLRF Requirements for APT
por: McCarthy, M
Publicado: (2001)

Aptly coined acronym
por: Devine, C.
Publicado: (2021)

Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients With Brain Glioma
por: Wamelink, Ivar J.H.G., et al.
Publicado: (2022)

Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma
por: Awuah, Dennis, et al.
Publicado: (2023)

Engineering Analysis of the APT Cryomodules
por: Campbell, B M, et al.
Publicado: (1999)

Plication: How apt in application?
por: Sharma, Pradeep, et al.
Publicado: (2017)

Alignment and Steering Scenarios for the APT Linac
por: Stovall, J E, et al.
Publicado: (1996)

Design, Analysis, and Fabrication of the APT Cavities
por: Atencio, S, et al.
Publicado: (1999)

APT weighted imaging in diffuse gliomas
por: Nichelli, Lucia, et al.
Publicado: (2023)

3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T
por: Wu, Yulun, et al.
Publicado: (2022)

Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population
Publicado: (1981)

Correction to: 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T
por: Wu, Yulun, et al.
Publicado: (2022)

APT CCDTL and CCL Thermal/Mechanical Analysis
por: Christiansen, D, et al.
Publicado: (2001)

APT LLRF Control System Functionality and Architecture
por: Regan, A H, et al.
Publicado: (1996)

Front-End Physics Design of APT Linac
por: Nath, S, et al.
Publicado: (1996)

APT Cryomodule Assembly Process and Mockup Model
por: Campbell, B, et al.
Publicado: (1999)

Development of the SCRF Power Coupler for the APT Accelerator
por: Schmierer, E N, et al.
Publicado: (1999)

Testing of Vacuum System for APT/LEDA RFQ
por: Shen, S, et al.
Publicado: (1999)

A Method for Cooling RF Waveguides on APT
por: McCarthy, M, et al.
Publicado: (1999)

Development of a Commissioning Plan for the APT Linac
por: Schulze, M E, et al.
Publicado: (1999)

Dr Sharad Vishwanath Apte (1930-2013)
por: Gorakshakar, Ajit C.
Publicado: (2013)

Providing contextually apt feedback in clinical education
por: Shaddel, Farshad, et al.
Publicado: (2018)

Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor
Publicado: (1986)

Review and consensus recommendations on clinical APT‐weighted imaging approaches at 3T: Application to brain tumors
por: Zhou, Jinyuan, et al.
Publicado: (2022)

Improving APT Systems’ Performance in Air via Impedance Matching and 3D-Printed Clamp
por: Liu, Liu, et al.
Publicado: (2023)

Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners
por: Wu, Yulun, et al.
Publicado: (2023)

Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature
por: Roberts, Jackson A., et al.
Publicado: (2023)

Oxidative Stress Contributes to Endothelial Dysfunction in Mouse Models of Hereditary Hemorrhagic Telangiectasia
por: Jerkic, Mirjana, et al.
Publicado: (2012)

Electrophoretic Deposition of Carbon Nanotubes on 3-Amino-Propyl-Triethoxysilane (APTES) Surface Functionalized Silicon Substrates
por: Sarkar, Anirban, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v6jp5r3o8vgjt5iohgh6odnmkb